Table 1.
Changes in Peripheral Blood and Bone Marrow During the Disease Process
| Date | Hemogram | Absolute Value of Monocyte (0/dl) | NK Cell Count (CD3-/CD16+56+) (40–1000×106/L) |
B Cell Count (CD19+) (50–670×106/L) |
Bone Marrow Blasts% | Myelodysplasia |
|---|---|---|---|---|---|---|
| 24 July 2014 | WBC 3,000/dl; HB 10.3g/dl PLT 86,000/dl |
0 | Unknow | Unknow | 3 | Dysplasia granulocyte and erythrocyte |
| 19 July 2017 | WBC 1,500/dl; HB 9.8g/dl PLT 50,000/dl |
0 | Unknow | Unknow | 2.5 | Trilineage Dysplasia |
| 11 April 2019 | WBC 1,700/dl; HB 8.8g/dl PLT 45,000/dl |
0 | 34×106/L | 6×106/L | 10 | Trilineage Dysplasia |
| 4 June 2019 | WBC 2,000/dl; HB 8.1g/dl PLT 26,000/dl |
0 | Not detected | Not detected | 5.5 | Dysplasia granulocyte and erythrocyte |
| 24 July 2019 | WBC 2,300/dl; HB 9.2g/dl PLT 31,000/dl (Platelet transfusion dependent) |
0 | 19×106/L | 11×106/L | 5 | Dysplasia granulocyte and erythrocyte |